Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Icona e-Study Subject

1.2.4 by Parallel 6, Inc.


Jan 24, 2020

Informazioni su e-Study Subject

Il Soggetto App è per gli iscritti al braccio virtuale della e-Study.

The e-Study Clinical Study has a family of Mobile Apps for use by patients, clinicians, and other health care professionals during the course of the e-Study Trial.

e-Study is itself a pilot to evaluate the methodology of a VIRTUAL clinical trial conducted in patients with Type 1 diabetes prior to performance of full-scale studies. The effect of conducting a VIRTUAL trial vs a TRADITIONAL trial will be analyzed in a variety of areas including study activities, the medication under investigation, medications not under investigation, medicinal product regulatory compliance, patient retention and much more in order to assess the value that a virtual methodology can bring.

There is a possibility that the information gained from e-Study may help others with this condition in the future.

The e-Study Subject App is for Patients enrolled in the VIRTUAL arm of the e-Study Clinical Trial. Please download the app and follow the prompts to begin using it.

Novità nell'ultima versione 1.2.4

Last updated on Jan 24, 2020

Bug fixes and enhancements.

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento e-Study Subject 1.2.4

Caricata da

Aiman Idris

È necessario Android

Android 5.0+

Mostra Altro

e-Study Subject Screenshot

Commento Loading...
Lingua
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.